Share on StockTwits
 

Investment analysts at Citigroup Inc. upped their price target on shares of Shire (LON:SHP) from GBX 3,200 ($52.50) to GBX 3,600 ($59.06) in a note issued to investors on Wednesday, Analyst Ratings Net reports. The firm currently has a “buy” rating on the stock. Citigroup Inc.’s target price would indicate a potential upside of 14.76% from the stock’s previous close.

SHP has been the subject of a number of other recent research reports. Analysts at UBS AG reiterated a “neutral” rating on shares of Shire in a research note on Tuesday. They now have a GBX 3,180 ($52.17) price target on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Shire in a research note on Friday, February 7th. They now have a GBX 3,370 ($55.29) price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Shire in a research note on Friday, February 7th. They now have a GBX 3,400 ($55.78) price target on the stock. One analyst has rated the stock with a sell rating, ten have issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Shire presently has a consensus rating of “Buy” and a consensus price target of GBX 2,533.99 ($41.57).

Shares of Shire (LON:SHP) traded down 0.70% during mid-day trading on Wednesday, hitting GBX 3141.00. 2,096,746 shares of the company’s stock traded hands. Shire has a 1-year low of GBX 1853.0001 and a 1-year high of GBX 3158.00. The stock’s 50-day moving average is GBX 2956.42 and its 200-day moving average is GBX 2673.. The company’s market cap is £17.225 billion.

Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.